Cargando…

Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study

Background. Peripheral arterial disease (PAD) and its relevant complications are more common in hemodialysis (HD) patients, while the evidence regarding antiplatelet therapy in CKD patients is scarce. We retrospectively analyzed the efficacy of cilostazol on outcomes in HD patients with asymptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Paik Seong, Jeng, Yachung, Wu, Ming Ying, Pai, Mei-Ann, Wu, Tsai-Kun, Chen, Chang Hsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055930/ https://www.ncbi.nlm.nih.gov/pubmed/27747241 http://dx.doi.org/10.1155/2016/8236903

Ejemplares similares

Serum Oxidized Albumin and Cardiovascular Mortality in Normoalbuminemic Hemodialysis Patients: A Cohort Study
por: Lim, Paik Seong, et al.
Publicado: (2013)

Proportions of Proinflammatory Monocytes Are Important Predictors of Mortality Risk in Hemodialysis Patients
por: Jeng, Yachung, et al.
Publicado: (2017)

Long-Term Effectiveness of Cilostazol in Patients with Hemodialysis with Peripheral Artery Disease
por: Wu, Chung-Kuan, et al.
Publicado: (2023)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Falconer, Travis M, et al.
Publicado: (2008)

Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease
por: Cha, Jung‐Joon, et al.
Publicado: (2023)

Impaired Gut Epithelial Tight Junction Expression in Hemodialysis Patients Complicated with Intradialytic Hypotension
por: Wu, Tsai-Kun, et al.
Publicado: (2018)

Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database
por: Real, Jordi, et al.
Publicado: (2018)

Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan
por: Lee, Chun-Chuan, et al.
Publicado: (2012)

Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol
por: Tseng, Kuang-Yi, et al.
Publicado: (2023)

Prevalence and Risk Factors of Asymptomatic Peripheral Arterial Disease in Patients with COPD in Taiwan
por: Lin, Ming-Shian, et al.
Publicado: (2013)

Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia
por: Sheu, Jiunn-Jye, et al.
Publicado: (2012)

Abdominal Obesity is Associated with Peripheral Artery Disease in Hemodialysis Patients
por: Hung, Peir-Haur, et al.
Publicado: (2013)

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
por: Liu, Jhih-Syuan, et al.
Publicado: (2015)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Cilostazol Ameliorates Peripheral Neuropathic Pain in Streptozotocin-Induced Type I Diabetic Rats
por: Cheng, Kuang-I., et al.
Publicado: (2022)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Peripheral Arterial Disease and Spinal Cord Injury: A Retrospective Nationwide Cohort Study
por: Su, Ta-Wei, et al.
Publicado: (2015)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Real world data from a multi-centre study on the effects of cilostazol on pain symptoms and walking distance in patients with peripheral arterial disease
por: Katsiki, Niki, et al.
Publicado: (2022)

Current Perspective on Hemodialysis Patients with Peripheral Artery Disease
por: Okamoto, Shin, et al.
Publicado: (2017)

Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
por: Ihara, Masafumi, et al.
Publicado: (2014)

Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
por: Kim, Kyu Seop, et al.
Publicado: (2011)

Association between peripheral arterial occlusive disease and cardiothoracic ratio in patients on chronic hemodialysis
por: Liou, Kang-Yi, et al.
Publicado: (2016)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
por: Tan, Choon Han, et al.
Publicado: (2021)

Safety and efficacy of cilostazol in the management of intermittent claudication
por: Chi, Yung-Wei, et al.
Publicado: (2008)

Cilostazol for the prevention of pneumonia: a systematic review
por: Nakashima, Hirotaka, et al.
Publicado: (2018)

Effects of cilostazol on the heart rate in healthy dogs
por: FUKUSHIMA, Ryuji, et al.
Publicado: (2018)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Population pharmacodynamics of cilostazol in healthy Korean subjects
por: Jung, Yun Seob, et al.
Publicado: (2018)

Negative correlation of serum adiponectin level with peripheral artery occlusive disease in hemodialysis patients
por: Lai, Yu-Hsien, et al.
Publicado: (2019)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC−MS/MS
por: Bhatt, Nejal M., et al.
Publicado: (2015)

Evaluation of a protocol for coronary artery disease investigation in asymptomatic elderly hemodialysis patients
por: De Lima, Jose Jayme G, et al.
Publicado: (2018)

Final Results of Cilostazol-Aspirin Therapy against Recurrent Stroke with Intracranial Artery Stenosis (CATHARSIS)
por: Uchiyama, Shinichiro, et al.
Publicado: (2015)

Effects of cilostazol on the progression and regression of symptomatic intracranial artery stenosis: it reduces the risk of ischemic stroke
por: Zhang, Wen-hui, et al.
Publicado: (2015)

The Effect of Cilostazol on Endothelial Function as Assessed by Flow-Mediated Dilation in Patients with Coronary Artery Disease
por: Mori, Hiroyoshi, et al.
Publicado: (2016)

Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study
por: Miura, Takashi, et al.
Publicado: (2022)

Link between Peripheral Artery Disease and Heart Rate Variability in Hemodialysis Patients
por: Chen, Szu-Chia, et al.
Publicado: (2015)

Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports
por: Yuan, Huai-Wu, et al.
Publicado: (2020)

Association between Flow-Mediated Dilation and Skin Perfusion Pressure with Peripheral Artery Disease in Hemodialysis Patients
por: Wung, Chih-Hsuan, et al.
Publicado: (2021)

Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients
por: Lin, Ting-Yun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_noueqhhsikmbedq32ggim761c2